THE DUBERSTEIN GROUP INC. for NORVARTIS CORP
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Healthcare reform, including follow-on biologics - HR 3200, To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes; HR 1427, To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes; HR 1548, To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes; S 726, A bill to amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes; proposed legislation re these issues. Flu preparedness issues - Executive Branch action re these issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL BERMAN | — |
| STEVEN CHAMPLIN | ExecFlrAsst, H. Maj. Whip; ExecDir, H.DemCauc. |
| KENNETH DUBERSTEIN | — |
| BRIAN GRIFFIN | Sr. Ldrship Advisor, Sen. Dorgan |
| DANIEL P MEYER | Asst. to President,Legis.Affairs, Pres. GW Bush |
| MARTI THOMAS | Acting & Asst Sec. Legis. Affrs, Treasury |
| ERIC UELAND | Sen.Maj.Ldr; AsstCOS/COS, Sen.Maj.Ldr. |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.